PIK3CA mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinoma
Open Access
- 24 May 2011
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 225 (2), 189-194
- https://doi.org/10.1002/path.2940
Abstract
Clear cell adenocarcinoma (CCA), a highly lethal histological subtype of ovarian carcinoma, is a type of human cancer with a high frequency of activating mutations in the PIK3CA gene. In this study, we aimed to determine how these mutations contribute to tumour development of CCAs. Exons 9 and 20 of the PIK3CA gene were analysed by direct genomic DNA sequencing of 23 CCAs with synchronous putative precursor lesions (ie endometriosis adjacent to carcinoma, with or without cytological atypia) and their mutational statuses were compared. Somatic mutations of the PIK3CA gene were detected in 10/23 (43%) carcinomas and in all cases the type of mutation was H1047R in the kinase domain. The identical H1047R mutation was also detected in the coexisting endometriotic epithelium, adjacent to the CCAs, in nine of ten (90%) cases. Moreover, in six of the nine lesions, the H1047R mutation was identified even in the endometrioses lacking cytological atypia. These findings provide evidence that mutations of the PIK3CA gene occur in the putative precursor lesions of CCA, strongly suggesting that they are very early events in tumourigenesis, probably initiating the malignant transformation of endometriosis. A specific kinase inhibitor to mutated PIK3CA may potentially be an effective therapeutic reagent against these carcinomas. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Funding Information
- Ministry of Defence, Japan
- Ministry of Health, Labour, and Welfare, Japan
This publication has 38 references indexed in Scilit:
- ARID1AMutations in Endometriosis-Associated Ovarian CarcinomasThe New England Journal of Medicine, 2010
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell CarcinomaScience, 2010
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying TheoryThe American Journal of Surgical Pathology, 2010
- Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell CarcinomaThe American Journal of Pathology, 2009
- Rare cancer-specific mutations in PIK3CA show gain of functionProceedings of the National Academy of Sciences of the United States of America, 2007
- Ovarian clear cell adenocarcinoma: a continuing enigmaJournal of Clinical Pathology, 2006
- Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical stagingBritish Journal of Cancer, 2006
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibThe New England Journal of Medicine, 2004
- Medical Therapy of EndometriosisSeminars in Reproductive Medicine, 2003